The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Ampitras 20% w/v, suspension for injection

20 percent weight/volume Suspension for injection

Kela n.v.VPA10981/006/001

Main Information

Trade NameAmpitras 20% w/v, suspension for injection
Active SubstancesAmpicillin
Strength20 percent weight/volume
Dosage FormSuspension for injection
Licence HolderKela n.v.
Licence NumberVPA10981/006/001

Group Information

ATC CodeQJ01CA01 ampicillin
Therapeutic ClassAntibacterial


Licence Issued01/10/1987
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back